A new heart-failure drug from the drug maker Novartis, has received FDA approved. The company claims that this drug helps reduce death and hospitalizations from heart failure. A lot of excitement has been building up in regards to this drug, Entresto, since the results of a large clinical trial showed a 20% reduction in the risk of death from cardiovascular disease or hospitalization from a worsening heart failure.